On May 14, 2024, the U.S. Food and Drug Administration (FDA) is hosting a webinar to discuss the final rule “Medical Devices; Laboratory Developed Tests” (LDTs).
FDA will provide an overview of the final rule amending the FDA’s regulations to make it explicit that in vitro diagnostic products (IVDs) are devices under the Federal Food, Drug, and Cosmetic Act, including when the manufacturer of the IVD is a laboratory; and describe the phaseout of the FDA’s general enforcement discretion approach to LDTs.
If you have questions about this webinar, contact the Division of Industry and Consumer Education.
- Webinar Date: Tuesday, May 14, 2024, from 1:00 PM – 2:00 PM ET
- Location: Webcast
- Registration: Not required
